OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alopecia Areata: Current Treatments and New Directions
Dante Dahabreh, Seungyeon Jung, Yael Renert‐Yuval, et al.
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 895-912
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
Hiroki L. Yamaguchi, Yuji Yamaguchi, Elena Peeva
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4409-4409
Open Access | Times Cited: 13

Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
Ala Ehsani, Zahra Razavi, Amirhossein Rahimnia, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access | Times Cited: 1

Amygdalin ameliorates alopecia areata on C3H/HeJ mice by inhibiting inflammation through JAK2/STAT3 pathway
Xun He, Jingsong Liu, Yugang Gong, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118317-118317
Closed Access | Times Cited: 7

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
Xin He, Dongyue Yang, Lingyao Lai, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 565-571
Open Access | Times Cited: 4

Alopecia Areata Is Associated with an Increased Risk for Prediabetes and Obesity: A Nationwide Case—Control Study
Yonit Wohl, Jacob Mashiah, Oberkovich Noy, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 1, pp. 16-16
Open Access

Future Prospects and Regulatory Pathways for Invasome Technologies in Transdermal Drug Delivery
Anil Kumar, Debayan Sil, Balak Das Kurmi, et al.
Assay and Drug Development Technologies (2025)
Closed Access

Nanoparticle Adjuvants Incorporating Haptens Drive Potent Immune Tolerance to Accelerate Hair Regrowth
Ni An, Guzailinuer Yasen, Ximu Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access

Mechanistic study of Erianin in alopecia areata
Xiaomei Xuan, Guoqiang Zhang, Jinfang Zhang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 1, pp. 550-559
Closed Access

Mechanism of PPARα agonist in alopecia areata
Xiaomei Xuan, Guoqiang Zhang, Jinfang Zhang, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 844-855
Closed Access

Janus kinase inhibitors for the treatment of lichen Sclerosus: A systematic review
Chin‐Hsuan Shen, Shu-Hui Wang, Ching‐Chi Chi
British Journal of Clinical Pharmacology (2025)
Closed Access

Tissue Engineering and Nanoparticle-Based Approaches for Hair Follicle Regeneration
Haluk Çelik, Ayça Bal‐Öztürk
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access

Tofacitinib en alopecia areata y síndrome nefrótico
Irene Comino-Hidalgo, Ana Belén Martínez-López, Minia Campos‐Domínguez, et al.
Anales de Pediatría (2025), pp. 503834-503834
Open Access

Sexual Dysfunction in Alopecia Areata: A Systematic Review
Piotr Krajewski, Aleksandra Złotowska, Jacek C. Szepietowski, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2602-2602
Open Access

Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
Yijia He, Jinxu Qi, Zhuochen Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Title Choice of treatment for severe forms of alopecia areata (case reports)
Yu. A. Gallyamova
Vestnik dermatologii i venerologii (2025)
Open Access

Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
Susan Farshi, Parvin Mansouri
Journal of Cosmetic Dermatology (2025) Vol. 24, Iss. 5
Open Access

Lasers in the management of alopecia: a review of established therapies and advances in treatment
Philippe Jean‐Pierre, Anika Pulumati, Eli Kasheri, et al.
Lasers in Medical Science (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3

Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
Ruixuan Guan, Yiling Lin, Cun Zhang, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Closed Access | Times Cited: 2

Role of interleukins in dermatology: Exploring the immune mechanisms in skin diseases
Álvaro Prados‐Carmona, F.J. Navarro‐Triviño, Ricardo Ruíz‐Villaverde, et al.
JEADV Clinical Practice (2024)
Open Access | Times Cited: 2

Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study
Jundong Huang, Qian Pei, Yan Tang, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv12425-adv12425
Open Access | Times Cited: 5

Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
Md Mehedi Hossain, Arfan Khalid, Zaheen Akhter, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

CS12192: A novel selective and potent JAK3 inhibitor mitigates acute graft-versus-host disease in bone marrow transplantation
Shengjian Huang, Qian‐Jiao Yang, You Zhou, et al.
Transplant Immunology (2024) Vol. 85, pp. 102075-102075
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top